- Home
- UNCY
as 06-20-2025 4:00pm EST
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | LOS ALTOS |
| Market Cap: | 91.0M | IPO Year: | 2021 |
| Target Price: | $6.38 | AVG Volume (30 days): | 867.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.02 - $11.00 | Next Earning Date: | 08-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 1458.53% |
Latest Unicycive Therapeutics Inc. News
UNCY Breaking Stock News: Dive into UNCY Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Unicycive Therapeutics to Implement 1-for-10 Reverse Stock Split
GlobeNewswire
4 days ago
Unicycive Therapeutics, Inc. Announces Reverse Stock Split
Simply Wall St.
10 days ago
Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m
MT Newswires
11 days ago
Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
MT Newswires
11 days ago
Top Premarket Decliners
MT Newswires
11 days ago
Unicycive Says US FDA Inspection Reveals Manufacturing Deficiencies for Oxylanthanum Carbonate Drug Candidate; Shares Down
GlobeNewswire
11 days ago
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
GlobeNewswire
a month ago
Unicycive Therapeutics to Present at Upcoming Investor Conferences
Compare UNCY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "UNCY Unicycive Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.